Duo Oncology

Pittsburgh, United States

Duo Oncology develops a new nanoparticle technology specially tailored to penetrate established tumors.

$3.0M raised

Feb 2023

Seed

Top Investors

Ulu VenturesBeiGeneInnovation WorksLifeX LabsNuFund Venture Group

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Duo Oncology raised?

Duo Oncology has raised $3.0M in total funding. The most recent round was Seed. The last funding was announced in February 2023.

Who are Duo Oncology's investors?

Duo Oncology's investors include Ulu Ventures, BeiGene, Innovation Works, LifeX Labs, NuFund Venture Group.

Where is Duo Oncology headquartered?

Duo Oncology is headquartered in Pittsburgh, United States.

What does Duo Oncology do?

Duo Oncology develops a new nanoparticle technology specially tailored to penetrate established tumors.

What stage is Duo Oncology at?

Duo Oncology is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 8, 2023.

MLA

"Duo Oncology — Funding & Investors." VCBacked, February 8, 2023, https://www.vcbacked.co/company/duo-oncology. Accessed June 13, 2026.

APA

VCBacked. (2023). Duo Oncology — Funding & Investors. Retrieved June 13, 2026, from https://www.vcbacked.co/company/duo-oncology

Wikipedia (cite web)

{{cite web |title=Duo Oncology — Funding & Investors |url=https://www.vcbacked.co/company/duo-oncology |website=VCBacked |access-date=June 13, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 8, 2023.